LONDON, July 5 (Reuters) – Britain is close to concurring a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.
The paper said that Britain was thinking about taking an alternative to purchase the vaccine ought to it operate in human trials, which are because of begin in September.
$ 1 = 0.8011 pounds
Reporting by Alistair Smout; Modifying by Elaine Hardcastle
Our Standards: The Thomson Reuters Trust Principles.